@article{oai:repo.qst.go.jp:00047090,
 author = {Murai, Kazunori and Akagi, Tomoaki and Shimosegawa, Kenji and Sugawara, Tomohiro and Ishizawa, Kenichi and Ito, Shigeki and Murai, Keiko and Motegi, Mutsuhito and Yokoyama, Hisayuki and Noji, Hideyoshi and Tajima, Katsushi and Kimura, Jun and Chou, Takaaki and Ogawa, Kazuei and Harigae, Hideo and Kubo, Kohmei and Oba, Koji and Sakamoto, Junichi and Ishida, Yoji and 田嶋 克史},
 journal = {European journal of haematology},
 month = {Mar},
 note = {We conducted a phase II study to evaluate the efficacy and safety of dasatinib in Japanese patients with imatinib-resistant or imatinib-intolerant chronic myeloid leukemia (CML).},
 title = {A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria.},
 year = {2015}
}